{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:55:31Z","timestamp":1791471331931,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016808","name":"Natural Science Foundation of Xiamen Municipality","doi-asserted-by":"publisher","award":["3502Z20191103"],"award-info":[{"award-number":["3502Z20191103"]}],"id":[{"id":"10.13039\/100016808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016808","name":"Natural Science Foundation of Xiamen Municipality","doi-asserted-by":"publisher","award":["3502Z20209007"],"award-info":[{"award-number":["3502Z20209007"]}],"id":[{"id":"10.13039\/100016808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010166","name":"Xiamen City Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470474"],"award-info":[{"award-number":["82470474"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270417"],"award-info":[{"award-number":["82270417"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023J01677"],"award-info":[{"award-number":["2023J01677"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023J01680"],"award-info":[{"award-number":["2023J01680"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejphar.2026.179333","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:38:37Z","timestamp":1789799917000},"page":"179333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PD-L1 antibody-induced cardiac dysfunction is regulated by CCR5-positive macrophages"],"prefix":"10.1016","volume":"1035","author":[{"given":"Jiale","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Da","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6831-0502","authenticated-orcid":false,"given":"Wei-Yin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binni","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3875-2112","authenticated-orcid":false,"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2026.179333_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2125.2008.03130.x","article-title":"Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers","volume":"65","author":"Abel","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179333_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02308-2018","article-title":"CCR2\/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension","volume":"54","author":"Abid","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2026.179333_bib3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/CIRCULATIONAHA.114.010757","article-title":"CCR5 as a treatment target in pulmonary arterial hypertension","volume":"130","author":"Amsellem","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179333_bib4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jacc.2019.11.049","article-title":"Global longitudinal strain and cardiac events in patients with immune checkpoint inhibitor-related myocarditis","volume":"75","author":"Awadalla","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179333_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCRESAHA.118.314028","article-title":"Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate Monocyte recruitment and fate specification following myocardial injury","volume":"124","author":"Bajpai","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.179333_bib5","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41591-018-0059-x","article-title":"The human heart contains distinct macrophage subsets with divergent origins and functions","volume":"24","author":"Bajpai","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2026.179333_bib7","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1161\/ATVBAHA.108.165423","article-title":"A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice","volume":"28","author":"Braunersreuther","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.179333_bib8","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.7150\/jca.54430","article-title":"Mechanism of PKM2 affecting cancer immunity and metabolism in Tumor microenvironment","volume":"12","author":"Chen","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.ejphar.2026.179333_bib9","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1161\/CIRCULATIONAHA.113.001278","article-title":"Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice","volume":"127","author":"Cipriani","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179333_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2018.09.008","article-title":"Targeting programmed cell death -1 (PD-1) and Ligand (PD-L1): a new era in cancer active immunotherapy","volume":"194","author":"Constantinidou","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2026.179333_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.immuni.2013.11.019","article-title":"Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation","volume":"40","author":"Epelman","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2026.179333_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","article-title":"Origin and functions of tissue macrophages","volume":"41","author":"Epelman","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2026.179333_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ame2.12266","article-title":"Overexpressed PKM2 promotes macrophage phagocytosis and atherosclerosis","volume":"6","author":"Gai","year":"2023","journal-title":"Animal Model. Exp. Med."},{"key":"10.1016\/j.ejphar.2026.179333_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.962596","article-title":"Cardiotoxicity associated with immune checkpoint inhibitors: current status and future challenges","volume":"13","author":"Gan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179333_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2174\/157016210793499295","article-title":"Long-term immunovirogical effect and tolerability of a maraviroc-containing regimen in routine clinical practice","volume":"8","author":"Genebat","year":"2010","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.ejphar.2026.179333_bib16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/INF.0000000000001808","article-title":"Pharmacokinetics, safety and efficacy of maraviroc in treatment-experienced pediatric patients infected with CCR5-Tropic HIV-1","volume":"37","author":"Giaquinto","year":"2018","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ejphar.2026.179333_bib17","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1186\/s12967-023-04780-6","article-title":"M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics","volume":"21","author":"Guo","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.179333_bib18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-physiol-022516-034348","article-title":"Macrophages and the recovery from acute and chronic inflammation","volume":"79","author":"Hamidzadeh","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2026.179333_bib19","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant Myocarditis with combination immune checkpoint blockade","volume":"375","author":"Johnson","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179333_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.yjmcc.2021.03.010","article-title":"Role of myeloid-derived chemokine CCL5\/RANTES at an early stage of atherosclerosis","volume":"156","author":"Jongstra-Bilen","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179333_bib21","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2019.01.044","article-title":"CCR5 is a therapeutic target for recovery after stroke and traumatic brain injury","volume":"176","author":"Joy","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179333_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000874","article-title":"CCR5 inhibition prevents cardiac dysfunction in the SIV\/macaque model of HIV","volume":"3","author":"Kelly","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2026.179333_bib24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccell.2022.12.008","article-title":"Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2026.179333_bib23","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2023.12947","article-title":"Shikonin improves pulmonary vascular remodeling in monocrotaline-induced pulmonary arterial hypertension via regulation of PKM2","volume":"27","author":"Li","year":"2023","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2026.179333_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jare.2020.09.001","article-title":"Iminostilbene, a novel small-molecule modulator of PKM2, suppresses macrophage inflammation in myocardial ischemia-reperfusion injury","volume":"29","author":"Lu","year":"2021","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejphar.2026.179333_bib26","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72418","article-title":"Analysis of combinatorial chemokine receptor expression dynamics using multi-receptor reporter mice","volume":"11","author":"Medina-Ruiz","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.ejphar.2026.179333_bib27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/eurheartj\/ehab430","article-title":"Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy","volume":"43","author":"Michel","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2026.179333_bib28","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1158\/1078-0432.CCR-18-3421","article-title":"Breast Phyllodes tumors recruit and repolarize tumor-associated macrophages via secreting CCL5 to promote malignant progression, which can be inhibited by CCR5 inhibition therapy","volume":"25","author":"Nie","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179333_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.exger.2017.12.025","article-title":"Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model","volume":"105","author":"Padron","year":"2018","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ejphar.2026.179333_bib30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2217\/imt-2018-0118","article-title":"Cardiotoxicity with immune system targeting drugs: a meta-analysis of anti-PD\/PD-L1 immunotherapy randomized clinical trials","volume":"11","author":"Rahouma","year":"2019","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ejphar.2026.179333_bib31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12265-022-10321-1","article-title":"Role of Pyruvate Kinase M2 (PKM2) in cardiovascular diseases","volume":"16","author":"Rihan","year":"2023","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ejphar.2026.179333_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00210-023-02593-4","article-title":"Inhibition of Pyruvate kinase M2 (PKM2) by shikonin attenuates isoproterenol-induced acute myocardial infarction via reduction in inflammation, hypoxia, apoptosis, and fibrosis","volume":"397","author":"Rihan","year":"2024","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ejphar.2026.179333_bib33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/QAD.0000000000002762","article-title":"Pharmacokinetics and safety of maraviroc in neonates","volume":"35","author":"Rosebush","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.ejphar.2026.179333_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-319-17121-0_2","article-title":"Role of chemokines in shaping macrophage activity in AMD","volume":"854","author":"Rutar","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2026.179333_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau8866","article-title":"Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity","volume":"11","author":"Saleme","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.179333_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jjco\/hyx154","article-title":"Immune checkpoint inhibitor-related myocarditis","volume":"48","author":"Tajiri","year":"2018","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2026.179333_bib37","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1161\/CIRCULATIONAHA.117.029626","article-title":"Cardiac toxicity of immune checkpoint inhibitors: Cardio-oncology meets immunology","volume":"136","author":"Varricchi","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179333_bib39","article-title":"CD147-K148me2-Driven Tumor cell-macrophage crosstalk provokes NSCLC immunosuppression via the CCL5\/CCR5 axis","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ejphar.2026.179333_bib38","article-title":"C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload","volume":"23","author":"Wang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2026.179333_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijantimicag.2019.02.018","article-title":"Efficacy and safety of long-term maraviroc use in a heterogeneous group of HIV-infected patients: a retrospective cohort study","volume":"54","author":"Weehuizen","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejphar.2026.179333_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001293","article-title":"PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor-related cardiac dysfunction","volume":"8","author":"Xia","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejphar.2026.179333_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006808","article-title":"Chordoma recruits and polarizes tumor-associated macrophages via secreting CCL5 to promote malignant progression","volume":"11","author":"Xu","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejphar.2026.179333_bib43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41569-024-01109-8","article-title":"Functional diversity of cardiac macrophages in health and disease","volume":"22","author":"Yang","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179333_bib44","article-title":"Blockade of CCR5(+) T cell accumulation in the tumor microenvironment optimizes Anti-TGF-beta\/PD-L1 bispecific antibody","volume":"11","author":"Yi","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ejphar.2026.179333_bib45","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s13046-022-02559-z","article-title":"The traditional Chinese medicine monomer Ailanthone improves the therapeutic efficacy of anti-PD-L1 in melanoma cells by targeting c-Jun","volume":"41","author":"Yu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179333_bib46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","article-title":"CCL5\/CCR5 axis in human diseases and related treatments","volume":"9","author":"Zeng","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.ejphar.2026.179333_bib51","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4049\/jimmunol.2200249","article-title":"CXCL16 promotes Ly6Chigh Monocyte infiltration and impairs heart function after acute myocardial infarction","volume":"210","author":"Zhang","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2026.179333_bib49","doi-asserted-by":"crossref","first-page":"10711","DOI":"10.1111\/jcmm.17007","article-title":"PKM2 promotes angiotensin-II-induced cardiac remodelling by activating TGF-beta\/Smad2\/3 and Jak2\/Stat3 pathways through oxidative stress","volume":"25","author":"Zhang","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2026.179333_bib48","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41422-021-00528-3","article-title":"Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling","volume":"31","author":"Zhang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.ejphar.2026.179333_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo1981","article-title":"Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis","volume":"14","author":"Zhang","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.179333_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13578-019-0317-8","article-title":"PKM2, function and expression and regulation","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:18:49Z","timestamp":1791469129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926008150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":51,"alternative-id":["S0014299926008150"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179333","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-L1 antibody-induced cardiac dysfunction is regulated by CCR5-positive macrophages","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179333"}}